loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: risedronate sodium anhydrous

    Client Email Product
    Menu

    risedronate sodium anhydrous

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 905Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 22560 / DOSAGE - TABLET, DELAYED RELEASE;ORAL - 35MG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    RISEDRONATE SODIUM HEMI-PENTAHYDRATE(UNII: HU2YAQ274O)
    (RISEDRONIC ACID - UNII:KM2Z91756Z)     		RISEDRONIC ACID30.1mg
    RISEDRONATE SODIUM MONOHYDRATE(UNII: F67L43UT5C)
    (RISEDRONIC ACID - UNII:KM2Z91756Z)     		RISEDRONIC ACID4.9mg

    Inactive Ingredients

    Ingredient Name
    Actavis Pharma, Inc.
    Teva Pharmaceuticals USA Inc
    CELLULOSE, MICROCRYSTALLINE(OP1R32D61U) 
    EDETATE DISODIUM(7FLD91C86K)
    FERRIC OXIDE YELLOW(EX438O2MRT) 
    MAGNESIUM STEARATE(70097M6I30)
    METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A(NX76LV5T8J)
    MICROCRYSTALLINE CELLULOSE(OP1R32D61U) 
    POLYSORBATE 80(6OZP39ZG8H)
    SILICON DIOXIDE(ETJ7Z6XBU4)
    SODIUM STARCH GLYCOLATE TYPE A POTATO(5856J3G2A2)
    STEARIC ACID(4ELV7Z65AP)
    TALC(7SEV7J4R1U)
    TRIETHYL CITRATE(8Z96QXD6UM)